F.D.A. Delays Action on Closely Watched Alzheimer’s Drug
Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.
¿Se puede tener alzhéimer y no presentar síntomas?
Una propuesta para cambiar los lineamientos de detección de la enfermedad podría tener un gran impacto en la cantidad de casos diagnosticados.
Cyberattack Paralyzes the Largest US Health Care Payment System
The hacking shut down the nation’s biggest health care payment system, causing financial chaos that affected a broad spectrum ranging from large hospitals to single-doctor practices.
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.
What to Know About Ibogaine, a Psychedelic
Some researchers hope the drug, still illegal in the United States, may be considered as a treatment for addiction, PTSD and brain injuries.
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.
First U.S. Over-the-Counter Birth Control Pill Will Be Available Soon
Opill will cost $19.99 per month or $49.99 for a three-month supply.
Apparently Healthy, but Diagnosed With Alzheimer’s?
New criteria could lead to a dementia diagnosis on the basis of a simple blood test, even in the absence of obvious symptoms.
Ozempic May Blow the Federal Budget
Ozempic threatens to bust the national budget. That may finally force the government to address the problem of overly expensive medical treatments.
CVS Fined $1.5 Million by Ohio Over Staffing Issues
The penalty is part of a settlement of 27 cases involving safety concerns revealed during inspections of nearly two dozen stores, officials said.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.